4.86  0.01 (0.21%)		04-28 16:00
Open: 4.68 High: 5.04 Volume: 7,367,281		Pre. Close: 4.85 Low: 4.55 Market Cap: 755(M)

Short term
Mid term
Targets	6-month :	5.88	1-year :	6.87
Resists	First :	5.03	Second :	5.88
Pivot price	3.61
Supports	First :	3.6	Second :	2.71
MAs	MA(5) :	4.26	MA(20) :	3.46
	MA(100) :	3.13	MA(250) :	3.08
MACD	MACD :	0.4	Signal :	0.2
%K %D	K(14,3) :	91.7	D(3) :	86.8
RSI	RSI(14): 80
52-week	High :	5.22	Low :	2.24

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ABSI ] has closed above the upper band by 0.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 190.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	4.87 - 4.91	4.91 - 4.94
Low:	3.85 - 3.88	3.88 - 3.91
Close:	4.8 - 4.86	4.86 - 4.9

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Tue, 28 Apr 2026
H.C. Wainwright reiterates Absci stock rating on hair loss data By Investing.com - Investing.com Australia

Tue, 28 Apr 2026
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Mon, 27 Apr 2026
Absci (NASDAQ:ABSI) Sees Large Volume Increase - Should You Buy? - MarketBeat

Mon, 27 Apr 2026
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mon, 27 Apr 2026
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - MSN

Sun, 26 Apr 2026
Absci Corp. (ABSI) Offering Impressive Upside to Potential Investors - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	153 (M)
Held by Insiders	1.4328e+008 (%)
Held by Institutions	13.3 (%)
Shares Short	38,490 (K)
Shares Short P.Month	0 (K)

EPS	-1.1298e+008
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-5 %
Return on Assets (ttm)	452.6 %
Return on Equity (ttm)	-36.3 %
Qtrly Rev. Growth	2.8e+006 %
Gross Profit (p.s.)	-1.15
Sales Per Share	-31.1
EBITDA (p.s.)	-3.87662e+007
Qtrly Earnings Growth	-0.9 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-93 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.16
Price to Cash Flow	7.81

Dividend	0
Forward Dividend	3.733e+007
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.